We use a procurement-friendly model: per-site setup plus per-session pricing (hardware kits available via partners). Grant funding de-risks evidence and MDR/GDPR readiness at TRL7–8; TRL9 scale-up is equity-financed. This aligns with provider workflows, budgeting cycles, and security review processes.
Does this include home use or B2C?
No. The project scope is clinic-based, supervised delivery only. There is no B2C/home-use app. Deployment prioritizes regulated environments with clinical governance, IT/security onboarding, and GDPR compliance (including DPIA and documented technical/organizational measures).
How is patient safety managed in practice?
Safety is layered: real-time physiological monitoring, the safety gate with clinician override, graded exposure to minimize motion sickness, and defined escalation pathways. Adverse events are monitored and reported per protocol; sessions run only under licensed professional supervision in clinical settings.
Is ZEST VR an autonomous therapy or a home-use product?
No. At this stage ZEST VR is delivered under licensed clinician supervision in regulated settings. It supports CBT/ACT-based sessions with adaptive VR scenarios and a validated safety gate (false-negative ≤ 5% with instant clinician override). Home-use/B2C is out of scope.